Judicialization of medicines: a systematic review of the literature in Brazil between the years 2015 and 2019
DOI:
https://doi.org/10.47456/rbps.v22i3.32533Keywords:
Judicialization of health, Judicialization of access to medicines, RighttohealthAbstract
Introduction: The judicialization of health, especially regarding the requisition of medicines, has become popular throughout the country, in which those who feel denied the right to access health, seek justice through the guarantee of access. However, sometimes judicialization for individual purposes starts to reverse the logic of the principles of the Unified Health System when it privileges only one individual and not the need for the collective. This context reflects weak points in public policies, which call for solutions that facilitate access to pharmaceutical assistance and minimize costs arising from judicialization. Objective: To identify studies about the judicialization of health, with a focus on medicines supply. Methods: This is a systematic review study based on Methodi Ordinatio, carried out in Scopus, Scielo and Science Direct databases, considering the years 2015 to 2019. Results: Of the total of 706 articles 16 were selected originating four categories: authors profile, characteristics of the causes, cost of medication judicialization and issues that permeate medication judicialization. Mostly Brazilian studies, with lawsuits filed by different age groups requesting low and high-cost drugs, predominantly for chronic diseases. Conclusion: The interference of the judiciary in the access to medicines aims to guarantee the right to health, but it interferes principles of the health system. The judicialization of medicines has been growing in the country, establishing the conflict between right to health guaranteed by the Federal Constitution and structuring of services for its effectiveness.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
